Related Experiment Video

Updated: Jul 28, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Risk factor modification through nonpharmacological interventions in patients with coronary heart disease

E H Sebregts1, P R Falger, F W Bär

  • 1Department of Medical, Clinical, and Experimental Psychology, Maastricht University, Postbus 616, 6200 MD, Maastricht, The Netherlands. ellen.sebregts@MP.unimaas.nl

Journal of Psychosomatic Research
|July 6, 2000
PubMed

Insights

Lifestyle changes are crucial for secondary prevention of coronary heart disease (CHD). Nonpharmacological interventions can improve risk factors like smoking, cholesterol, and Type A behavior, potentially reducing CHD progression and mortality.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Behavioral Science

Background:

  • Coronary heart disease (CHD) remains a leading cause of mortality in developed nations.
  • Improved acute myocardial infarction treatments increase the importance of secondary CHD prevention.
  • Behavioral factors significantly contribute to CHD development and progression.

Purpose of the Study:

  • To review the effects of nonpharmacological interventions on risk factor modification for secondary CHD prevention.
  • To assess the impact of lifestyle and exercise interventions on CHD outcomes.

Main Methods:

  • Systematic review of randomized, controlled clinical trials.
  • Focus on nonpharmacological interventions in patients with established CHD.
  • Analysis of interventions targeting smoking cessation, cholesterol levels, Type A behavior, lifestyle, and exercise.

Main Results:

  • Healthy lifestyle interventions promote smoking cessation and reduce total and LDL-cholesterol.
  • Interventions can favorably modify Type A behavior in CHD patients.
  • Intensive lifestyle and exercise interventions show potential for reducing coronary atherosclerosis, CHD morbidity, and mortality.

Conclusions:

  • Nonpharmacological, behavior-focused interventions are vital for secondary CHD prevention.
  • Lifestyle and exercise modifications offer significant benefits for CHD patients.
  • Further research is needed on interventions for hypertension and obesity in secondary CHD prevention.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...